ATE470351T1 - Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht - Google Patents

Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht

Info

Publication number
ATE470351T1
ATE470351T1 AT02803565T AT02803565T ATE470351T1 AT E470351 T1 ATE470351 T1 AT E470351T1 AT 02803565 T AT02803565 T AT 02803565T AT 02803565 T AT02803565 T AT 02803565T AT E470351 T1 ATE470351 T1 AT E470351T1
Authority
AT
Austria
Prior art keywords
mouse
gene
tlr7
synthetic compound
animal model
Prior art date
Application number
AT02803565T
Other languages
English (en)
Inventor
Shizuo Akira
Hideyuki Tomizawa
Takashi Yamaoka
Original Assignee
Japan Science & Tech Agency
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency, Dainippon Sumitomo Pharma Co filed Critical Japan Science & Tech Agency
Application granted granted Critical
Publication of ATE470351T1 publication Critical patent/ATE470351T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02803565T 2001-11-22 2002-11-22 Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht ATE470351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001358295 2001-11-22
PCT/JP2002/012234 WO2003043588A1 (fr) 2001-11-22 2002-11-22 Modele animal non humain ne reagissant pas a un compose synthetique d'immunopotentialisation

Publications (1)

Publication Number Publication Date
ATE470351T1 true ATE470351T1 (de) 2010-06-15

Family

ID=19169496

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02803565T ATE470351T1 (de) 2001-11-22 2002-11-22 Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht

Country Status (6)

Country Link
US (1) US7608750B2 (de)
EP (1) EP1459727B1 (de)
AT (1) ATE470351T1 (de)
CA (1) CA2468011C (de)
DE (1) DE60236686D1 (de)
WO (1) WO2003043588A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
US20120122867A1 (en) * 2009-05-21 2012-05-17 Nicholas James Bennet Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
WO2011068226A1 (ja) * 2009-12-03 2011-06-09 株式会社アウレオ マクロファージ貪食能活性化組成物および／またはマクロファージにおけるサイトカイン産生促進組成物
NZ602000A (en) * 2010-02-22 2015-05-29 Edge Therapeutics Inc Methods and compositions to treat hemorrhagic conditions of the brain
JP6336899B2 (ja) 2011-04-05 2018-06-06 エッジ セラピューティクス インコーポレイテッド 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム
CN113373178A (zh) * 2021-08-13 2021-09-10 上海南方模式生物科技股份有限公司 一种tlr8基因人源化动物模型的构建方法及应用
WO2024012578A1 (zh) * 2022-07-15 2024-01-18 百奥赛图(北京)医药科技股份有限公司 一种tlr7和/或tlr8基因人源化修饰的非人动物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943240B2 (en) * 2000-09-15 2005-09-13 Coley Pharmaceuticals Gmbh Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
AU2002343728A1 (en) * 2001-11-16 2003-06-10 3M Innovative Properties Company Methods and compositions related to irm compounds and toll-like receptor pathways

Also Published As

Publication number Publication date
CA2468011A1 (en) 2003-05-30
WO2003043588A1 (fr) 2003-05-30
US7608750B2 (en) 2009-10-27
EP1459727A4 (de) 2006-09-06
CA2468011C (en) 2012-04-10
EP1459727A1 (de) 2004-09-22
JP4493336B2 (ja) 2010-06-30
EP1459727B1 (de) 2010-06-09
US20050235372A1 (en) 2005-10-20
DE60236686D1 (de) 2010-07-22
JPWO2003043588A1 (ja) 2005-03-10

Similar Documents

Publication Publication Date Title
Albadri et al. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish
Niedermeyer et al. Expression of the fibroblast activation protein during mouse embryo development.
Kanki et al. High-efficiency CAG-FLPe deleter mice in C57BL/6J background
Ding et al. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice
WO1999053017A3 (en) Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
ATE315085T1 (de) Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren.
ATE470351T1 (de) Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht
Chan et al. Optimising homing endonuclease gene drive performance in a semi-refractory species: the Drosophila melanogaster experience
KR20210134059A (ko) 조작된 면역글로불린 람다 경쇄 유전자좌를 갖는 비인간 동물
RU2014153918A (ru) Способы и композиции для получения условно нокаутных аллелей
TR201903376T4 (tr) Çok fonksiyonlu alleller.
Xie et al. Generation of Axin1 conditional mutant mice
US7700356B2 (en) System for gene targeting and producing stable genomic transgene insertions
Mortensen Overview of gene targeting by homologous recombination
WO2005038001A3 (en) Improved transgenesis by sperm-mediated gene transfer
US7473557B2 (en) Method for targeting transcriptionally active loci
Eferl et al. Simultaneous generation of fra‐2 conditional and fra‐2 knock‐out mice
WO2010138397A1 (en) Caveolin 1-reporter protein knock-in mouse
JP2011518566A5 (de)
JP4811765B2 (ja) 外来遺伝子の誘導発現の制御が可能な発現ベクター
EP1712126A4 (de) Transgener vogel und verfahren zu seiner herstellung
CA2416949A1 (en) Non-human animal model unresponsive to mycoplasma derived lipoprotein/lipopeptide
WO2000030437A8 (en) Transgenic animals
WO2005037994A3 (en) Transgenic rodents selectively expressing human b1 bradykinin receptor protein
Wallace et al. Inactivation of the murine Transferrin Receptor 2 gene using the Cre recombinase: loxP system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties